UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Misregulated wnt/β-catenin signaling leads to ovarian granulosa cell tumor development

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9206-9215

2005

Link zum Volltext

Verfügbarkeit prüfen

Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group

British journal of cancer, 2013-01, Vol.108 (1), p.49-57

2013

Link zum Volltext

Verfügbarkeit prüfen

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

Oncology, 2005-01, Vol.68 (4-6), p.326-332

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion

Cancer chemotherapy and pharmacology, 2011-11, Vol.68 (5), p.1331-1337

2011

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

British journal of cancer, 2011-07, Vol.105 (3), p.360-365

2011

Link zum Volltext

Verfügbarkeit prüfen

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2597-2606

2013

Link zum Volltext

Verfügbarkeit prüfen

Chordoma and chondrosarcoma gene profile: implications for immunotherapy

Cancer Immunology, Immunotherapy, 2009-03, Vol.58 (3), p.339-349

2009

Link zum Volltext

Verfügbarkeit prüfen

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

British journal of cancer, 2006-11, Vol.95 (9), p.1148-1154

2006

Link zum Volltext

Verfügbarkeit prüfen

Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome

International journal of hematology, 2009-07, Vol.90 (1), p.87-90

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients

British journal of cancer, 2012-06, Vol.107 (1), p.37-42

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

British journal of cancer, 2006-10, Vol.95 (7), p.794-800

2006

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

British journal of cancer, 2006-04, Vol.94 (7), p.1007-1010

2006

Link zum Volltext

Verfügbarkeit prüfen

Relationship of p53 with other Oncogenes, Cytokines and Systemic Lupus Erythematosus Activity

Tumor biology, 2003-08, Vol.24 (4), p.185-188

2003

Link zum Volltext

Verfügbarkeit prüfen

State Disparities in Colorectal Cancer Mortality Patterns in the United States

Cancer epidemiology, biomarkers & prevention, 2011-07, Vol.20 (7), p.1296-1302

2011

Link zum Volltext

Verfügbarkeit prüfen

DICER1 hotspot mutations in non-epithelial gonadal tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2744-2750

2013

Link zum Volltext

Verfügbarkeit prüfen

Frequent deletion of the CDKN2A locus in chordoma : analysis of chromosomal imbalances using array comparative genomic hybridisation

British journal of cancer, 2008-01, Vol.98 (2), p.434-442

2008

Link zum Volltext

Verfügbarkeit prüfen

Highly Purified Müllerian Inhibiting Substance Inhibits Human Ovarian Cancer in Vivo

Clinical cancer research, 2002-08, Vol.8 (8), p.2640-2646

2002

Link zum Volltext

Verfügbarkeit prüfen

Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS

Clinical cancer research, 1999-11, Vol.5 (11), p.3488-3499

1999

Link zum Volltext

Verfügbarkeit prüfen

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK SAPK and bad death pathways

British journal of cancer, 2007-03, Vol.96 (6), p.918-927

2007

Link zum Volltext

Verfügbarkeit prüfen

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials

Cancer treatment reviews, 2014-06, Vol.40 (5), p.675-683

2014

Link zum Volltext

Verfügbarkeit prüfen

In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)

Cancer Immunology, Immunotherapy, 2009-02, Vol.58 (2), p.209-220

2009

Link zum Volltext

Verfügbarkeit prüfen

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity

British journal of cancer, 2013-11, Vol.109 (10), p.2560-2565

2013

Link zum Volltext

Verfügbarkeit prüfen

Survival in Hodgkin’s disease patients – Report of 25 years of experience at the Milan Cancer Institute

European journal of cancer (1990), 2005-05, Vol.41 (7), p.998-1006

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

British journal of cancer, 2014-01, Vol.110 (2), p.271-277

2014

Link zum Volltext

Verfügbarkeit prüfen

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning

Cancer Immunology, Immunotherapy, 2008-03, Vol.57 (3), p.367-378

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid

PublikationsformDissertationen

PublikationsformNewsletter-Artikel

ThemaHumans

ThemaMedical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(55)
Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Tumors
(40)
Female
(37)
Adult
(25)
Middle Aged
(22)
Male
(21)
Aged
(17)
Pharmacology. Drug Treatments
(16)
Cancer Research
(15)
Hematologic And Hematopoietic Diseases
(14)
Antineoplastic Agents
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(12)
Medicine
(12)
Medicine & Public Health
(12)
Animals
(11)

12 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Misregulated wnt/β-catenin signaling leads to ovarian granulosa cell tumor development

Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

Chordoma and chondrosarcoma gene profile: implications for immunotherapy

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

Relationship of p53 with other Oncogenes, Cytokines and Systemic Lupus Erythematosus Activity

State Disparities in Colorectal Cancer Mortality Patterns in the United States

DICER1 hotspot mutations in non-epithelial gonadal tumours

Frequent deletion of the CDKN2A locus in chordoma : analysis of chromosomal imbalances using array comparative genomic hybridisation

Highly Purified Müllerian Inhibiting Substance Inhibits Human Ovarian Cancer in Vivo

Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK SAPK and bad death pathways

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials

In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity

Survival in Hodgkin’s disease patients – Report of 25 years of experience at the Milan Cancer Institute

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning

Aktive Filter

Suchergebnisse filtern